Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 580
Selected: 0
NCT IDTitle
NCT00080665Docetaxel and Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Breast Cancer
NCT04117074Thoracic Epidural Analgesia vs Surgical Site Infiltration With Liposomal Bupivacaine Following Open Gynecologic Surgery
NCT03307564Radiopaque Hydrogel in Patients Undergoing Radiotherapy for Pancreatic Cancer
NCT03471286A Window of Opportunity Study to Investigate Mechanisms of Actions of Novel Therapeutic Agents in Patients With Resectable Solid Tumor Malignancies
NCT01804634Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
NCT03861676Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT
NCT00478062Vaccine Therapy in Treating Patients Who Have Received First-Line Therapy for Hodgkin's Lymphoma
NCT00287989Erlotinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer
NCT03619655Assessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to Therapy
NCT00006358Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor
NCT00022724CCI-779 in Treating Patients With Malignant Glioma
NCT00809991Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the Prostate
NCT01194427A Study of Vorinostat and Tamoxifen in Newly Diagnosed Breast Cancer
NCT00303927Capecitabine as Second-Line Therapy in Treating Patients With Stage IV Pancreatic Cancer Who Have the Thymidylate Synthase Gene
NCT06122480Surgical Resection of Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma
NCT02212574Study Assessing the Feasibility of a Surgery and Chemotherapy-Only in Children With Wnt Positive Medulloblastoma
NCT05014776Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer
NCT00867308Trial of High Dose Lenalidomide in Patients With MDS and AML With Trilineage Dysplasia
NCT01937052Johns Hopkins Breast Cancer Program Hormone Therapy Longitudinal Database
NCT06315257A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients
NCT00072449Rituximab in Treating Patients With Refractory or Relapsed Primary CNS Lymphoma
NCT00010049Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma
NCT06836648Single Patient Compassionate Use of X-PACT in Salvage Treatment of Prostate Cancer
NCT06536881Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming
NCT03886493Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate Cancer
NCT00068770Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT
NCT05658731Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients
NCT01886105Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma
NCT01653834Feasibility of Lymphocyte Reinfusion in Newly Diagnosed High Grade Gliomas
NCT03707444A Pilot Trial of Scrambler Therapy for Pain Associated With Pancreas Cancer
NCT03638141CTLA-4 /PD-L1 Blockade Following Transarterial Chemoembolization (DEB-TACE) in Patients With Intermediate Stage of HCC (Hepatocellular Carcinoma) Using Durvalumab and Tremelimumab
NCT05083754Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma
NCT03914794A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors
NCT03603002Pathologic and Immunologic Response After Ablative Radiation in Lung Cancer
NCT04447651Patient Response to Immunotherapy Using Spliceosome Mutational Markers (PRISMM)
NCT02965755Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins
NCT01088815Hedgehog Inhibitors for Metastatic Adenocarcinoma of the Pancreas
NCT03507608Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression
NCT02489799Utilizing Advance Care Planning Videos to Empower Perioperative Cancer Patients and Families
NCT01435499Safety Study of a Melanoma Vaccine (GVAX) With or Without Cyclophosphamide in Patients With Surgically Resected Melanoma
NCT01983709Allogeneic Human Bone Marrow Derived Mesenchymal Stem Cells in Localized Prostate Cancer
NCT03497377Evaluation of 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer.
NCT00003961Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome
NCT02259621Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC
NCT07140315DK222 Study at Hopkins
NCT00404248Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma
NCT049261686 Months Adjuvant Temozolomide (TMZ) vs No Adjuvant TMZ in Newly Diagnosed MGMT Methylated Glioblastoma (GBM)
NCT00770471ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
NCT01752036Radiotherapy for Solid Tumor Spine Metastases
NCT00276744Individualized Drug Treatment for Treating Patients With Pancreatic Cancer